9th October 2019
- 0 comments
Inflexion Private Equity has agreed to acquire Pharmaspectra, a leading global provider of medical affairs data to the pharmaceutical and biotech industry. The investment is being made by Inflexion Enterprise Fund IV, Inflexion’s dedicated lower mid?market fund.
Founded in 2005, Pharmaspectra is the leader in providing scientific dissemination data and analytics to the pharmaceutical industry. Pharmaspectra’s data is utilised by 7 of the world’s top 10 pharmaceutical companies. The firm has offices in the UK, US, Switzerland, and India.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.